Delivery Order SPE2DB22D2007-SPE2DB24FH9VC
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The contract, valued at $8,880.15, is for the delivery of Venclexta 100 mg tablets to support military treatment programs and facilities. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide a comprehensive range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 120 Venclexta 100 mg tablets. The $8,880.15 contract has a completion date of February 15, 2024. AmerisourceBergen Drug Corp is the prime contractor and there are no indications of any set-aside designations. This delivery order is issued under a larger indefinite delivery contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug Venclexta 100 mg tablets. The contract is a delivery order with a firm fixed price of $8,880.15 and a completion date of May 16, 2024. Amerisourcebergen, through its Corporate Office Division, holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical, which...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,880.15 firm fixed-price contract is for the delivery of 120 tablets of the medication Venclexta (100 mg), with a period of performance through September 17, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, received a $8,880.15 firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide 100 mg Venclexta tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the supply of the prescription medication Venclexta 100 mg tablets. The $8,880.15 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, with a performance period through June 18, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $8,880.15 firm fixed-price delivery order is for the supply of the pharmaceutical product Venclexta 100 mg tablets. The contract has an ultimate completion date of July 24, 2024 and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 contract is for the supply of 4,567,998,903 units of the prescription medication Venclexta 100 mg tablets. The award has an ultimate completion date of May 13, 2025 and is not set aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, valued at $8,880.15, was issued by the Defense Logistics Agency (DLA) to the pharmaceutical distributor AmerisourceBergen Drug Corp. The contract is a delivery order for the supply of the medication Venclexta 100 mg tablets, with an ultimate completion date of November 14, 2024. The contract is not designated as a set-aside and was awarded on a firm-fixed price basis. AmerisourceBergen, a major healthcare solutions provider, maintains an Indefinite Delivery...
- This is a $17,760.30 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Venclexta 100 mg tablets to support military treatment programs and facilities. The delivery order has an ultimate completion date of April 26, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH9VCDelivery Order
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $8,880.15 order is for 120 tablets of the pharmaceutical drug Venclexta 100 mg. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations mentioned. The award is associated with a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. Amerisourcebergen Drug Corp also holds an indefinite delivery contract with the Department of Justice Federal Bureau of Investigation Headquarters Division to provide medical supplies and prescription medications, valued at up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 2/21/24 |